Listed

Celldex Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Mar 7, 2019 and accepted by EDGAR at Mar 7, 2019, 16:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2018-01-01 to 2018-12-31$9.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2018-01-01 to 2018-12-31$700.0kus-gaap:CostOfGoodsAndServicesSold
Research and development12 months2018-01-01 to 2018-12-31$66.4mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-01-01 to 2018-12-31−$156.4mus-gaap:OperatingIncomeLoss
Income tax12 months2018-01-01 to 2018-12-31−$765.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-10-01 to 2018-12-31−$9.4mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2018-01-01 to 2018-12-31−$151.2mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2018-10-01 to 2018-12-31−$0.81us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2018-01-01 to 2018-12-31−$14.48us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-01-01 to 2018-12-31−$75.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-01-01 to 2018-12-31$813.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-12-31$24.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$99.1mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$155.8mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$12.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$31.7mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31$124.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-19-000992. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.